Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era

被引：2
|
作者：
Vasseur, Loic [1 ]
Prevot, Sophie [2 ,3 ]
Mounier, Nicolas [4 ]
Costagliola, Dominique [5 ]
Besson, Caroline [1 ,6 ,7 ]
机构：
[1] Versailles Hosp, Hematol Oncol Unit, Le Chesnay, France
[2] Univ Paris Sud, Fac Med Paris Sud, Le Kremlin Bicetre, France
[3] Hop Paris Sud, AP HP, Pathol Unit, Site Beclere, Clamart, France
[4] Archet Hosp, Dept Oncohematol, Nice, France
[5] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, Paris, France
[6] Univ Paris Saclay, Communaute Paris Saclay, Univ Versailles St Quentin Yvelines, Paris, France
[7] Gustave Roussy, Ctr Rech Epidemiol & Sante Populat CESP, Equipe Generat & Sante, INSERM,U1018, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
B-CELL LYMPHOMA; HODGKIN-LYMPHOMA; RITUXIMAB;
D O I：
10.1016/j.ejca.2020.07.033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：189 / 192
页数：4
相关论文
共 50 条
  • [41] Antiretroviral therapy in the treatment of HIV-associated nephropathy
    Atta, Mohamed G.
    Gallant, Joel E.
    Rahman, M. Hafizur
    Nagajothi, Nagapradeep
    Racusen, Lorraine C.
    Scheel, Paul J.
    Fine, Derek M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (10) : 2809 - 2813
  • [42] HIV-associated parkinsonism reversed with antiretroviral therapy
    Cheng, Yu-Wen
    Lin, Chin-Hsien
    Wu, Ruey-Meei
    NEUROLOGY ASIA, 2014, 19 (02) : 199 - 203
  • [43] Are tubuloreticular inclusions less frequently observed in HIV-associated nephropathy in the era of antiretroviral therapy?
    Williams, BA
    Wei, A
    Brand, DA
    Patrick, PA
    Burns, GC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 379A - 379A
  • [44] HIV-associated community-acquired pneumonia in the highly active antiretroviral therapy era
    Viale, P
    Scudeller, L
    Signorini, L
    Cadeo, B
    Petrosillo, N
    Pagani, L
    Carosi, G
    AIDS, 2002, 16 (17) : 2361 - 2362
  • [45] Discontinuation of prophylaxis for HIV-associated opportunistic infections in the era of highly active antiretroviral therapy
    Hermsen, ED
    Wynn, HE
    McNabb, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (03) : 245 - 256
  • [46] Clinical characteristics of HIV-associated Kaposi's sarcoma in the era of combination antiretroviral therapy
    Meyer, L.
    Stoehr, A.
    Horst, H. -A
    Plettenberg, A.
    Lorenzen, T.
    Schewe, K.
    Sabranski, M.
    Hoffmann, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 175 - 175
  • [47] Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy
    Batterham, MJ
    Garsia, R
    Greenop, P
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (11) : 744 - 747
  • [48] Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia
    O'Bryan T.A.
    Okulicz J.F.
    Bradley W.P.
    Ganesan A.
    Wang X.
    Agan B.K.
    BMC Research Notes, 8 (1)
  • [49] HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms?
    Payne, B. A. I.
    Hateley, C. L.
    Ong, E. L. C.
    Premchand, N.
    Schmid, M. L.
    Schwab, U.
    Newton, J. L.
    Price, D. A.
    HIV MEDICINE, 2013, 14 (04) : 247 - 251
  • [50] HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
    Heaton, R. K.
    Clifford, D. B.
    Franklin, D. R.
    Woods, S. P.
    Ake, C.
    Vaida, F.
    Ellis, R. J.
    Letendre, S. L.
    Marcotte, T. D.
    Atkinson, J. H.
    Rivera-Mindt, M.
    Vigil, O. R.
    Taylor, M. J.
    Collier, A. C.
    Marra, C. M.
    Gelman, B. B.
    McArthur, J. C.
    Morgello, S.
    Simpson, D. M.
    McCutchan, J. A.
    Abramson, I.
    Gamst, A.
    Fennema-Notestine, C.
    Jernigan, T. L.
    Wong, J.
    Grant, I.
    NEUROLOGY, 2010, 75 (23) : 2087 - 2096
12345